The MarketReader Minute
💊 Regeneron Falls on Amgen Biosimilar Ruling, Biogen Drops, and Revolution Medicines Slips Amid Sector Weakness | Biotech Sector Insights
(IBB) has declined by 1.5% during market hours on Wednesday. Recent social media discussions have noted a prediction from betting markets of a Republican sweep in the upcoming November elections, which could benefit IBB.